Signaling and Mechanistic Insights into Folate Binding Protein-Induced Cytotoxicity in KB Cancer Cells
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c00966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Hajar Samadian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, Monash University, Clayton, Victoria 3800, Australia. Hauptthemen laut MEDLINE: Signal Transduction. Die Arbeit nennt 99 Literaturangaben. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
A recent study on folate binding protein (FBP), the soluble form of a folate receptor (FR), revealed surprising inhibition of in vivo growth of KB cell-derived xenograft tumors in mice and the induction of in vitro caspase-mediated apoptosis in KB, HeLa, and A549 cells in culture. In this research, we investigated the mechanism(s) underlying FBP-induced cytotoxicity and apoptosis in FR-overexpressing KB cancer cells using next-generation sequencing (NGS), a high-throughput technology for RNA sequencing and gene expression profiling, followed by bioinformatics analysis. The transcriptomics data, in addition to immunofluorescence analyses, indicated over and under expression of many proteins and transcription factors, such as Snail1, MCP-1 (CCL2), ZFP36, and HOXA9 in KB cells after treatment with 50 μM FBP for 6, 12, and 24 h. The alteration of an expression level in these genes, which are involved in epithelial to mesenchymal transition (EMT), inflammatory, and apoptosis pathways, is consistent with the induction of folate deficiency in FBP-exposed KB cells. The temporal effect of 50 μM FBP on DNA breakage and the induction of apoptosis, examined by the TUNEL assay, also supports the hypothesis of FBP-mediated folate deprivation of KB cells. The evidence reported in this study sheds light on the mechanism of FBP cytotoxicity in FR-overexpressing KB cancer cells in culture and suggests possible pathways for the observation of inhibited growth for KB xenograft tumors in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biological Engineering, Monash University, Clayton, Victoria 3800, Australia.
- Department of Materials Science and Engineering, Monash University, Clayton, Victoria 3800, Australia.
- Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria 3800, Australia.
- Cancer Program, Monash Biomedicine Discovery Institute, Clayton, Victoria 3800, Australia.
- Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States.
- Department of Cellular and Molecular Signalling, The Institute of Biomedicine and Biotechnology of Cantabria, CSIC-University of Cantabria, Santander 39011, Spain.
ORCID-Profile: Mark M Banaszak Holl
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Samadian, H., Dyson, J. M., Pradeep, R., Rosa-Garrido, M., & Banaszak Holl, M. M. (2026). Signaling and Mechanistic Insights into Folate Binding Protein-Induced Cytotoxicity in KB Cancer Cells. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00966
Vancouver
Samadian H, Dyson JM, Pradeep R, Rosa-Garrido M, Banaszak Holl MM. Signaling and Mechanistic Insights into Folate Binding Protein-Induced Cytotoxicity in KB Cancer Cells. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c00966
BibTeX
@article{Samadian2026,
author = {Samadian, Hajar and Dyson, Jennifer M and Pradeep, Rujula and Rosa-Garrido, Manuel and Banaszak Holl, Mark M},
title = {Signaling and Mechanistic Insights into Folate Binding Protein-Induced Cytotoxicity in KB Cancer Cells},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c00966}
}
EUVIMED